Detalhe da pesquisa
1.
Do we have to exclude all relapsed diffuse large B-cell lymphoma patients not in complete remission from autologous stem cell transplant?
Br J Haematol
; 200(1): 13-14, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36120952
2.
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective study.
Br J Haematol
; 201(4): 673-681, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799516
3.
Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA.
Blood
; 137(17): 2307-2320, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33211799
4.
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Blood
; 137(19): 2646-2656, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512419
5.
ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study.
Haematologica
; 108(6): 1590-1603, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453105
6.
[Immunopathology of the small intestine]. / Immunopathologie de l'intestin grêle.
Ann Pathol
; 43(3): 252-265, 2023 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-37156715
7.
Oncogenetic landscape of lymphomagenesis in coeliac disease.
Gut
; 71(3): 497-508, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579790
8.
De novo generation of the NPM-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells.
Mol Cancer
; 21(1): 65, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35246138
9.
Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study.
Cancer
; 128(3): 519-528, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605020
10.
Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study.
Ann Hematol
; 101(2): 317-332, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34617134
11.
Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study.
Acta Oncol
; 61(11): 1332-1338, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214787
12.
Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa.
Ann Hematol
; 100(11): 2813-2824, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387741
13.
Vascular access for optimal hematopoietic stem cell collection.
J Clin Apher
; 36(1): 12-19, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32854142
14.
Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma.
Retrovirology
; 17(1): 5, 2020 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32199462
15.
NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.
Gut
; 68(8): 1396-1405, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30448772
16.
Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study.
Br J Haematol
; 187(1): 65-72, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31215036
17.
New perspectives in the therapeutic approach of peripheral T-cell lymphoma.
Curr Opin Oncol
; 30(5): 285-291, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096094
18.
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.
Haematologica
; 107(7): 1681-1686, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965701
19.
Correction to: Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study.
Ann Hematol
; 101(2): 333, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694443
20.
Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group.
Haematologica
; 101(4): 474-81, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26721893